FDA Approved: * June 14, 2021
Pharm Company: * AMNEAL
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Etravirine Overview

Etravirine (ETR,[1] brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.[2] Etravirine is marketed by Tibotec, a subsidiary of Johnson & Johnson. In January 2008, the Food and Drug Administration approved its use for pati...

Read more Etravirine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Etravirine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 100mg, 200mg, 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Etravirine: (3 results)

Sorted by National Drug Code
  • 60219-1720 Etravirine 25 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 60219-1721 Etravirine 100 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC
  • 60219-1722 Etravirine 200 mg Oral Tablet by Amneal Pharmaceuticals Ny LLC

Other drugs which contain Etravirine or a similar ingredient: (1 result)